Elementis stock analysis
Elementis (EMNSF) Stock Price & Analysis
EMNSF Stock Chart & Stats
- Day’s Range
- $2.34 - $2.34
- 52-Week Range
- $1.81 - $2.77
- Previous Close
- $2.34
- Volume
- N/A
- Average Volume (3M)
- 748
- Market Cap
- $1.43B
- Enterprise Value
- $1.03B
- Total Cash (Recent Filing)
- $86.65M
- Total Debt (Recent Filing)
- $264.50M
- Price to Earnings (P/E)
- 19.8
- Beta
- 0.73
- Next Earnings
- Mar 11, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 14, 2026
- Dividend Yield
- 1.87%
Bulls Say, Bears Say
Bulls Say
Deleveraging
The sharp reduction in debt materially lowers financial risk and interest burden while improving resilience through the business cycle. With debt-to-equity around 0.11 and a sizable equity base, Elementis has greater flexibility to fund operations and pursue strategic priorities.
Positive Cash Generation
Positive operating and free cash flow demonstrates that Elementis’s business continues to convert customer demand into internally generated funds. This supports investment, debt service, and operational resilience without relying as heavily on external financing.
Operating Margin Improvement
The return to a strong operating margin indicates meaningful improvement in underlying business performance despite weaker revenue. If sustained, better operating profitability can strengthen cash generation, support reinvestment, and improve earnings quality over the coming quarters.
Bears Say
Revenue Decline
The revenue contraction signals weaker customer demand or mix across Elementis’s end markets and reduces the scale available to absorb fixed costs. Continued top-line pressure could limit growth investment and make the recent operating improvement harder to sustain.
Persistent Net Losses
Ongoing net losses show that improved operating performance has not yet translated into sustainable bottom-line profitability. This weakens shareholder returns, constrains internally funded growth, and indicates that below-the-line costs or one-off charges remain material.
Softening Cash Flow Momentum
Although cash generation remains positive, the decline in free cash flow and weaker conversion from EBIT point to reduced cash-flow quality and momentum. If this persists, Elementis may have less capacity for investment, shareholder distributions, or further balance-sheet improvement.
Elementis News
EMNSF FAQ
What was Elementis’s price range in the past 12 months?
What is Elementis’s market cap?
When is Elementis’s upcoming earnings report date?
How were Elementis’s earnings last quarter?
Is Elementis overvalued?
Does Elementis pay dividends?
What is Elementis’s EPS estimate?
How many shares outstanding does Elementis have?
What happened to Elementis’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Elementis?
What is the TipRanks Smart Score and how is it calculated?
Elementis Stock Smart Score
Company Description
Elementis
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. This segment offers products for applications in antiperspirants, skin care, and color cosmetics. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Lucas van Ravenstein
- Employees
- 989
- Website
- www.elementis.com
- Address
- The Bindery, London, GL, EC1N 8HN, GB
Elementis (EMNSF) Earnings & Revenues
EMNSF Earnings Call
Earnings Call SentimentPositive
The call shows a constructive transformation story: management delivered profit growth, margin expansion (+150 bps), strong Personal Care outperformance (revenue +2.4%, profit +16.9%, margin +410 bps), record innovation (16.4%) and continued cost-savings and sustainability progress. Offsetting these positives are modest revenue decline (-1.0% reported / -1.9% CC), Coatings weakness (revenue down ≈3.5% and margin compression), lower free cash flow ($41M vs $51M) and higher leverage (1.3x). Strategic portfolio moves (Alchemy acquisition, Talc sold, pharma disposal) sharpen focus and are accretive over time but change scale. On balance the highlights — margin expansion, EPS growth (+14.2%), successful cost programs, innovation momentum and clear strategic direction — slightly outweigh the near-term operational and macro headwinds.
View all EMNSF earnings summariesEMNSF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 12 |
| Technical Analysis | 3 | 3 | 2 |
| Moving Averages | 2 | 0 | 10 |












